Smallcap Radiopharm notches +12% jump on pancreatic cancer imaging win
The overall profile of Radiopharm Theranostics’ (ASX:RAD) pancreatic cancer imaging drug RAD…
Radiopharm Theranostics Limited (ASX:RAD)
About Radiopharm Theranostics Limited
Key Information
RAD In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 10.12am 18/11/2024 | Price Sensitive PS RAD 301 shows strong imaging potential in pancreatic cancer | 263.54KB | 591 |
| 29/10/2024 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 1.97MB | 1.9K |
| 25/10/2024 | Notice of Annual General Meeting | 674.27KB | 2.6K |
| 23/10/2024 | Change of Director's Interest Notice - IT | 167.28KB | 319 |
| 23/10/2024 | RAD 202 data presented at 2024 EANM Annual Meeting | 205.37KB | 276 |
| 21/10/2024 | BAMF Health to manufacture & dose for RAD101 Phase 2b trial | 205.23KB | 1.0K |
| 16/10/2024 | RAD partners with AtomVie to develop B7H3 trial doses | 232.53KB | 1.8K |
| 03/10/2024 | Initial Director's Interest Notice - ND | 227.43KB | 267 |